AICAR (50mg)

(20 customer reviews)


AICAR peptides are Synthesized and Lyophilized in the USA.

Discount per Quantity

Quantity 5 - 910 +
Discount 5%10%
Price $53.20$50.40

Out of stock

SKU: AICAR-50mg Category:


AICAR Peptide

AICAR or 5-Aminoimidazole-4-carboxamide ribonucleotide, is a synthetic adenosine monophosphate analog. It was developed to stimulate the AMP-dependent protein kinase (AMPK) activity.[1] [2] It is currently being investigated as a protective agent against ischemic damage in the cardiac myocytes during cardiac injury. The AMP-activated protein kinase is an enzyme and a protein that may play a regulatory role in several metabolic pathways. Its expression has been observed in several tissues, including the skeletal muscles, liver, and brain. In all these tissues, it has a potential net effect on lipogenesis and may inhibit cholesterol synthesis and ketogenesis. It may also modulate insulin secretion and skeletal muscle fatty acid oxidation with glucose uptake. Several energy deficit states may trigger the release of AMPK, like hypoxia or hypoglycemia.


SYNONYMS: Z-nucleotide, 5-amino-4-imidazolecarboxamide ribotide, 5′-Phosphoribosyl-5-amino-4-imidazolecarboxamide

MOLECULAR WEIGHT: 338.213 g/mol




AICAR Research

AICAR and the Heart
AICAR has been researched for its potential two-way protective role in protecting the heart from the ischemia associated with CVD. Inflammation is considered to be a significant contributor to the disease pathology in atherosclerosis and other heart diseases. Research on rabbits posited that AICAR may suppress vascular smooth muscle proliferation.[3] The control of vascular inflammation may reduce the risk of short-term and long-term complications of stent placement and may also contribute to the heart’s overall health. One of the immune responses that may trigger a heart attack is macrophage proliferation in response to high LDL (bad cholesterol) levels. AICAR may play a role in suppressing this immune response.[4]
AICAR has been studied for its potentially protective properties post-heart attack, with researchers suggesting that the peptide may act by delaying the process of cell death through preconditioning. By the same coin, AICAR, in an ischemic heart, has been suggested to possibly reduce the frequency and size of the infarct by up to 25%. It may also improve the overall blood flow to the heart.
One study aimed to investigate the mechanisms potentially involved in promoting myocardial glycogenolysis through the activation of AMPK.[5] The experiments were apparently conducted using isolated working hearts from halothane-anesthetized murine models. The hearts were perfused in the absence or presence of AICAR, an adenosine analog suggested to activate AMPK and potentially penetrate cells. The researchers observed that AICAR potentially increased glycogen degradation (glycogenolysis) in the myocardium, while glycogen synthesis apparently remained unaffected. This finding apparently suggests that AMPK activation potentially plays a specific role in glycogenolysis. Additionally, AICAR apparently increased the levels of myocardial 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranotide (ZMP), which is the active intracellular form of AICAR. However, AICAR did not alter the apparent activity of glycogen synthase (GS) and glycogen phosphorylase (GP) when measured in tissue homogenates, nor did it apparently affect the levels of glucose-6-phosphate and adenine nucleotides in freeze-clamped tissue. This finding potentially suggests that ZMP may hypothetically allosterically activate GP, potentially leading to glycogenolysis in the intact murine model heart.[5]

AICAR and Insulin Resistance
Insulin resistance is considered to result from reduced sensitivity of muscles to insulin and increased uptake in the fatty tissues, which also leads to increased levels of inflammation. This process results in raised insulin and blood glucose levels. The suppression of inflammation results in increased insulin sensitivity with improved glucose homeostasis. AICAR may improve insulin sensitivity and lipid metabolism via its possible anti-inflammatory role in different metabolic pathways. In diabetic murine models, AICAR was observed to reduce blood glucose levels without weight changes[6]. AICAR appears to mimic the effect that physical activity has on glucose uptake by muscles. It has the potential to upregulate the GLUT-4 receptors on muscles that are prime transporters involved in glucose uptake.
There was another study that investigated the potential mechanisms underlying the effects AMPK activation on the prevention of obesity-related diabetes using murine models.[7] It has been hypothesized that AMPK, a key regulator of glucose and lipid metabolism, may mediate many of the beneficial effects of physical activity on these processes. To examine the potential impact of long-term physical exertion and AMPK activation, male Zucker diabetic fatty (ZDF) murine models, known as a genetic model of type 2 diabetes, were utilized. These murine models were either subjected to daily treadmill running or AICAR, a considered activator of AMPK, over 8 weeks. They were then compared to a control group. The study’s outcome suggested that both the exercised murine models and the AICAR murine models did not develop hyperglycemia (high blood sugar levels) during the intervention period, unlike the control group. Furthermore, it appears that whole-body insulin sensitivity, which refers to the murine model ability to respond to and utilize insulin effectively, may have been improved in the exercised and AICAR murine models compared to the control ZDF murine models. This improvement in insulin sensitivity may indicate enhanced glucose metabolism and reduced insulin resistance, potentially important factors in developing type 2 diabetes. Additionally, the morphology of pancreatic beta cells, responsible for producing insulin, apparently appeared to be nearly normal in the exercised and AICAR murine models. This observation suggests that chronic activation of AMPK may potentially help preserve beta-cell function, which is typically impaired in type 2 diabetes. Considering all these factors, it may be posited that “suggest that activation of AMPK may represent a therapeutic approach to improve insulin action and prevent a decrease in beta-cell function associated with type 2 diabetes.”

AICAR and Cancer
AICAR, via its AMPK activation, may play a role in cancer cell metabolism. In research conducted on cell cultures and rats, prolonged AICAR influence appeared to slow down the metabolism of cancer cells and hence their proliferation.[8] It also may make the cancerous cells more vulnerable to harsh environmental factors. This vulnerability in cancer cells may support future AICAR trials. Thyroid cancer cell research has also suggested that AICAR may induce apoptosis in cancer cells by p21 induction and caspase-3 activations, potentially causing inhibition of cancer cell proliferation.
Further, one study suggested that AICAR may induce apoptosis in all tested samples of B-CLL (B-cell chronic lymphocytic leukemia) cells.[9] The study suggests that the activation of caspase-3, -8, and -9, as well as the release of cytochrome c, may be involved in AICAR-induced apoptosis. Furthermore, it appears that incubating B-CLL cells with AICAR potentially leads to the phosphorylation of AMPK, indicating a potential activation of this protein by AICAR. To investigate the necessity of AICAR incorporation into the cell and its subsequent phosphorylation to AICA ribotide (ZMP) for inducing apoptosis, the study used various inhibitors. Nitrobenzylthioinosine (NBTI), a nucleoside transport inhibitor, 5-iodotubercidin, an inhibitor of adenosine kinase, and adenosine were suggested to potentially inhibit AICAR-induced apoptosis and AMPK phosphorylation. In contrast, inhibitors of protein kinase A and mitogen-activated protein kinases apparently did not protect B-CLL cells from AICAR-induced apoptosis. Additionally, AICAR was not observed tot affect the levels or phosphorylation of p53, suggesting that the mechanism of apoptosis triggered by AICAR in B-CLL cells may be p53-independent. The study also compared the sensitivity of normal B lymphocytes and T cells to AICAR-induced apoptosis. Both normal B lymphocytes and B-CLL cells were suggested to be equally sensitive to AICAR-induced apoptosis. However, T cells from B-CLL subjects suggested only slight sensitivity to AICAR. Interestingly, AMPK phosphorylation potentially did not occur in T cells exposed to AICAR. Moreover, when both B-CLL cells and T cells were exposed to AICAR, intracellular levels of ZMP were apparently higher in B-CLL cells compared to T cells. This suggests that the accumulation of ZMP potentially plays a role in activating AMPK and inducing apoptosis. Overall, the scientists commented that AICAR may present a promising “new pathway involving AMPK in the control of apoptosis in B-CLL cells”[9]

AICAR and Fertility
A large amount of AICAR research has been directed toward its proposed action in possibly improving male fertility. Various studies on murine models have observed that AMPK activation appears to potentially improve fertility.[10] Since AICAR is an apparently effective AMPK activator, its long-term influence may improve sperm motility. Since AICAR may regulate the activity of all the active enzymes involved in sperm motility, its presentation has the potential to provide a profound positive effect on fertilization.

AICAR and Inflammation
AMPK activation appears to have an overall anti-inflammatory effect at a cellular level. Inflammation forms a part of the pathogenesis of several diseases. The same is valid for diabetes, making AICAR a potential subject for diabetic research. But its potential as an anti-inflammatory in disease processes does not stop here. Animal research has suggested its potential positive impact on various inflammatory disorders like hepatitis, acute lung injury, asthma, colitis, and atherosclerosis.[11] To conclude, AICAR may have significant cardioprotective properties. It has been studied for its possible ability to improve metabolic health and associated complications.
Further, one study focused on the mechanisms that potentially underlie the activation of AMPK and its apparent effects on glucose transport in muscle cells.[12] The researchers hypothesized the role of AMPK activators, specifically AICAR, and physical activity in potentially interacting with atypical protein kinase C (aPKC) and extracellular signal-regulated kinase (ERK) in muscle cells. In cultured L6 myotubes, the activation of AMPK by AICAR may be necessary to activate aPKC and ERK. The activation of aPKC seemingly involves the phosphorylation of Thr410-PKC-ζ potentially by phosphoinositide-dependent kinase 1 (PDK1). Furthermore, the phosphorylation and activation of aPKC at Thr410 may require the involvement of MEK1-dependent ERK. The researchers suggested that the effects of AICAR on glucose transport were potentially inhibited when dominant-negative AMPK, kinase-inactive PDK1, MEK1 inhibitors, kinase-inactive PKC-ζ, or RNA interference (RNAi)-mediated knockdown of PKC-ζ were introduced. To further investigate the role of aPKC, murine models were studied. Muscle-specific depletion of aPKC (PKC-λ) appeared to impair AICAR-induced glucose disposal, as well as the potentially stimulatory effects of AICAR on glucose uptake in muscle. Interestingly, the activation of AMPK appeared to remain unaffected in these conditions. In contrast, treadmill exercise-induced stimulation of glucose uptake was not apparently inhibited in aPKC-knockout murine models, suggesting that aPKC activation may potentially not be necessary for exercise-induced increases in glucose transport. Finally, the study examined the potential activation of aPKC in muscle and liver tissues of intact rodents. They suggested that aPKC was potentially activated by AICAR in muscle but not in the liver, despite the activation of AMPK in both tissues.[12]
Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.


  1. Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995). 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. European journal of biochemistry, 229(2), 558–565.
  2. Sun, N., Youle, R. J., & Finkel, T. (2016). The Mitochondrial Basis of Aging. Molecular cell, 61(5), 654–666.
  3. Stone, J. D., Narine, A., & Tulis, D. A. (2012). Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase. Frontiers in physiology, 3, 409.
  4. Ishii, N., Matsumura, T., Kinoshita, H., Motoshima, H., Kojima, K., Tsutsumi, A., Kawasaki, S., Yano, M., Senokuchi, T., Asano, T., Nishikawa, T., & Araki, E. (2009). Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation. The Journal of biological chemistry, 284(50), 34561–34569.
  5. Longnus, S. L., Wambolt, R. B., Parsons, H. L., Brownsey, R. W., & Allard, M. F. (2003). 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms. American journal of physiology. Regulatory, integrative and comparative physiology, 284(4), R936–R944. 
  6. Buhl, E. S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S. B., Pedersen, O., Schmitz, O., & Lund, S. (2002). Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes, 51(7), 2199–2206.
  7. Pold, R., Jensen, L. S., Jessen, N., Buhl, E. S., Schmitz, O., Flyvbjerg, A., Fujii, N., Goodyear, L. J., Gotfredsen, C. F., Brand, C. L., & Lund, S. (2005). Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes, 54(4), 928–934. 
  8. Su, C. C., Hsieh, K. L., Liu, P. L., Yeh, H. C., Huang, S. P., Fang, S. H., Cheng, W. C., Huang, K. H., Chiu, F. Y., Lin, I. L., Huang, M. Y., & Li, C. Y. (2019). AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway. International journal of molecular sciences, 20(7), 1647.
  9. Campàs, C., Lopez, J. M., Santidrián, A. F., Barragán, M., Bellosillo, B., Colomer, D., & Gil, J. (2003). Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood, 101(9), 3674–3680. 
  10. Martin-Hidalgo, D., Hurtado de Llera, A., Calle-Guisado, V., Gonzalez-Fernandez, L., Garcia-Marin, L., & Bragado, M. J. (2018). AMPK Function in Mammalian Spermatozoa. International journal of molecular sciences, 19(11), 3293.
  11. Idrovo, J. P., Yang, W. L., Jacob, A., Aziz, M., Nicastro, J., Coppa, G. F., & Wang, P. (2015). AICAR attenuates organ injury and inflammatory response after intestinal ischemia and reperfusion. Molecular medicine (Cambridge, Mass.), 20(1), 676–683.
  12. Sajan, M. P., Bandyopadhyay, G., Miura, A., Standaert, M. L., Nimal, S., Longnus, S. L., Van Obberghen, E., Hainault, I., Foufelle, F., Kahn, R., Braun, U., Leitges, M., & Farese, R. V. (2010). AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. American journal of physiology. Endocrinology and metabolism, 298(2), E179–E192.
All orders ship same day if placed by 12 PST.
This product is strictly for research/laboratory use only.  Human or animal use and/or consumption is strictly prohibited by law.  Only qualified and licensed professionals should handle these products.  Any information found on Biotech Peptides is strictly for educational purposes only.  Refer to our terms and conditions for more details.

Additional information


Biotech Peptides

20 reviews for AICAR (50mg)

  1. Chloe Hamilton

    They are amazing with customer service. The other day I had ordered a few types of peptides including MOD GRF 1-29. Turns out they had run out of stock and immidiatly called to inform me of what was happening. They offered me either full refund or just to send whatever they had in stock as their shipment of this peptide was running late. I jusr asked for them to send whatever peptides they could and refund me on the ones that are missing. Hung up and went on with my day and the next morning got an email that they recieved their Mod grf this morning and would send it as soon as possible. Love it! They had my payment already in file but I needed to confirm but so happy that they remembered me and sought me out. I think the person I was dealing with was Dani!

  2. Skye Gordon

    Shipment was fast. I had got a confirmation number in the morning and recieved it by the end of the day!

  3. Theo Heuett

    It is really frustrating for me to see such an amazing company with such oustanding products go downhill in reviews because of the shipping company. I understand it is not your fault, but c’mon, change the shipping company if they destroy your business.

  4. Wenye Dang

    I have no complaints so far. I’ve ordered from them a few times and one time one of the boxes came chipped in a corner, but that was about it.

  5. Jenny Lee

    The customer experience in this company is second to none. Came for the products, stayed for the experience and quality.

  6. Melanie Cruz

    Biotech has been my peptide supplier for months now. I have never had to wait for a restock (could be luck) but they are on top of keeping up with demand.

  7. Alice Eve

    I guess this peptide is pretty popular with them cause it gets out of stock pretty quickly. Thankful I don’t need it often.

  8. Emma Miller

    They are one of the few peptide suppliers that have real and good quality peptides!

  9. Ava Martinez

    Thanks for the free bac water!

  10. Amy F.

    Thank you for always having the best quality peptides! Consistency is great.

  11. Amar Habib

    My company has been working with BP for a few years now and they are great! Never had any mistakes with them.

  12. Yakima Gal

    I’ve searched for this product ALL OVER the internet and on the few sites where I found it, it cost a fortune. I feel very lucky to have found it here. Nice selection and reasonable prices.

  13. Felix Hernandez

    Was recommended to them a little while back. Now i’m the one recommending them to others!

  14. matt long

    My experience with Biotech has been great. I have had an issue with them only once where they charged me twice for an order. That was quickly handled through email actually. Other than that great company.

  15. Troy Perkins

    Used to work with another peptide company, I switched over due to their constant sales and better pricing for better quality peptides.

  16. walter forbs

    Afforable and good quality peptides is what you get here.

  17. Cooper Qualls

    Thanks for the free bac waters with my orders!!

  18. Ahmad khalili

    I was assisted by Jamie and they were able to handle my situation quickly and efficiently. Peptides I had purchased showed up and a few of them appeared to have been broken or oxidized while in transit. Jamie was able to correct this and sent me a new batch of peptides and also gave a discount code for my next purchase as well.

  19. Bill Korreck

    Shipping was fast and peptides looked to be in great condition as well. Packaging doesn’t look the safest but it did the job!

  20. Jessica Aber

    Lot of frequent sales!

Add a review